Con: Aprotinin Should Not Be Used in Cardiac Surgery With Cardiopulmonary Bypass

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 21, Issue 2, 2007, Pages 302-304

  Augoustides, John G T ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

aprotinin; cardiac surgery; cardiopulmonary bypass

Indexed keywords

EID: 34047181182     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2007.01.002     Document Type: Note

References (29)

1. Royston D., Bidstrup B.P., Taylor K.M., et al. Effect of aprotinin on the need for blood transfusion after repeat open-heart surgery. Lancet 2 (1987) 1289-1291
2. Alajmo F., Calamai G., Perna A.M., et al. High-dose aprotinin: Hemostatic effects in open-heart operations. Ann Thorac Surg 48 (1989) 536-539
3. Karkouti K., Wijeysundera D.N., Yau T.M., et al. The independent association between massive blood loss with mortality in cardiac surgery. Transfusion 44 (2004) 1453-1462
4. Sundt III T.M., Kouchoukos N.T., Saffitz J.E., et al. Renal dysfunction and intravascular coagulation with aprotinin and hypothermic circulatory arrest. Ann Thorac Surg 55 (1993) 1418-1424
5. Dietrich W., Dilthey G., Spannagl M., et al. Influence of high-dose aprotinin on anticoagulation, heparin requirement, and celite- and kaolin-activated clotting time in heparin-pretreated patients undergoing open-heart surgery. A double-blind, placebo-controlled study. Anesthesiology 83 (1995) 679-689
6. Alderman E.L., Levy J.H., Rich J.B., et al. Analyses of coronary artery graft patency after aprotinin use: Results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial. J Thorac Cardiovasc Surg 116 (1998) 716-730
7. Sedrakyan A., Treasure T., and Elefteriades J.A. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: A systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg 128 (2004) 442-448
8. Erhlich M., Grabenwoger M., Cartes-Zumelzu F., et al. Operations on the thoracic aorta and hypothermic circulatory arrest: Is aprotinin safe?. J Thorac Cardiovasc Surg 115 (1998) 220-225
9. Mangano D.T., Tudor J.C., Dietzel C., et al. The risk associated with aprotinin in cardiac surgery. N Engl J Med 354 (2006) 353-365
10. Karkouti K., Beattie W.S., Dattilo K.M., et al. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Transfusion 46 (2006) 327-338
11. Augoustides J.G., Pochettino A., Ochroch E.A., et al. Renal dysfunction after thoracic aortic surgery requiring deep hypothermic circulatory arrest: definition, incidence, and clinical predictors. J Cardiothorac Vasc Anesth 20 (2006) 673-677
12. Fergusson D., Glass K.C., Hutton B., et al. Randomized controlled clinical trials of aprotinin in cardiac surgery: Could clinical equipoise have stopped the bleeding?. Clin Trials 2 (2005) 218-232
13. Augoustides JG, Fleisher LA: Comment on: Fergusson D, Glass KC, Hutton B, et al: Randomized controlled clinical trials of aprotinin in cardiac surgery: Could clinical equipoise have stopped the bleeding? Clin Trials 2:232-233, 2005
14. Body S.C., and Mazer C.D. Pro: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery. Anesth Analg 103 (2006) 1354-1359
15. Beattie W.S., and Karkouti K. Con: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery. Anesth Analg 103 (2006) 1360-1364
16. Beierlein W., Scheule A.M., Dietrich W., et al. Forty years of clinical aprotinin use: A review of 124 hypersensitivity reactions. Ann Thorac Surg 79 (2005) 7412-7418
17. Augoustides J.G., Kilbaugh T., Harris H., et al. Fatal thrombosis after mitral valve replacement for endocarditis: Aprotinin and disseminated intravascular coagulation. Anesthesiology 104 (2006) 213
18. Augoustides J.G., Lin J., Gambone A.J., et al. Fatal thrombosis in an adult after thoracoabdominal aneurysm repair with aprotinin and deep hypothermic circulatory arrest. Anesthesiology 103 (2005) 215-216
19. Shore-Lesserson L., and Reich D. A case of severe diffuse venous thromboembolism associated with aprotinin and hypothermic circulatory arrest in a cardiac surgical patient with factor V Leiden. Anesthesiology 105 (2006) 219-221
20. Mangano D.T., Miao Y., Vuylsteke A., et al. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA 297 (2007) 471-479
21. Kincaid E.H., Ashburn D.A., Hoyle J.R., et al. Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery?. Ann Thorac Surg 80 (2005) 1388-1393
22. Sedrakyan A., Wu A., Sedrakyan G., et al. Aprotinin use in thoracic aortic surgery: Safety and outcomes. J Thorac Cardiovasc Surg 132 (2006) 909-917
23. Mora Mangano C.T., Neville M.J., Hsu P.H., et al. Aprotinin, blood loss, and renal dysfunction in deep hypothermic circulatory arrest. Circulation 104 (2001) I1276-I1281
24. Cooper W.A., O' Brien S.M., Thourani V.H., et al. Impact of renal dysfunction on outcomes of coronary artery bypass surgery: Results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation 113 (2006) 1063-1070
25. Bennett-Guerrero E., Sorohan J.G., Gurevich M.L., et al. Cost-benefit and efficacy of aprotinin compared with epsilon-aminocaproic acid in patients having repeated cardiac operations: A randomized, blinded clinical trial. Anesthesiology 87 (1997) 1373-1380
26. Cooper Jr. J.R., Abrams J., Frazier O.H., et al. Fatal pulmonary microthrombi during surgical therapy for end-stage heart failure: Possible association with antifibrinolytic therapy. J Thorac Cardiovasc Surg 131 (2006) 963-968
27. Fanashawe M.P., Shore-Lesserson L., and Reich D. Two cases of fatal thrombosis after aminocaproic acid therapy and deep hypothermic circulatory arrest. Anesthesiology 95 (2001) 1525-1527
28. Henry D.A., Moxey A.J., Carless P.A., et al. Anti-fibrinolytic use for minimizing perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 1 (2001) CD001886
29. Mazer D., Fergusson D., Herbert P., et al. Incidence of massive bleeding in a blinded randomized controlled trial of antifibrinolytic drugs in high-risk cardiac surgery. Anesth Analg 102 (2006) SCA95